1-(3-chlorophenyl)piperazine has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 1 studies
1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vassallo, CM | 1 |
Feldman, E | 1 |
Peto, T | 1 |
Castell, L | 1 |
Sharpley, AL | 1 |
Cowen, PJ | 1 |
1 other study available for 1-(3-chlorophenyl)piperazine and Chronic Fatigue and Immune Dysfunction Syndrome
Article | Year |
---|---|
Decreased tryptophan availability but normal post-synaptic 5-HT2c receptor sensitivity in chronic fatigue syndrome.
Topics: Adult; Fatigue Syndrome, Chronic; Female; Fenfluramine; Humans; Male; Middle Aged; Piperazines; Prol | 2001 |